Perioperative management of pheochromocytoma: Anaesthetic implications

Journal of the Pakistan Medical Association

Volumn 57, Issue 3, 2007, Pages 140-146

  Ahmed, Aliya ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATENOLOL; ATRACURIUM; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; FENTANYL; GLYCERYL TRINITRATE; INSULIN; MAGNESIUM SULFATE; METOPROLOL; MIDAZOLAM; MIVACURIUM; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; OPIATE; PHENOXYBENZAMINE; PHENTOLAMINE; PRAZOSIN; PROPOFOL; PROPRANOLOL; REMIFENTANIL; SUXAMETHONIUM; TERAZOSIN; THIOPENTAL; ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; CATECHOLAMINE;

ANESTHESIA; CANCER SURGERY; CATECHOLAMINE RELEASE; CENTRAL VENOUS CATHETER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; EPIDURAL CATHETER; HEART ARRHYTHMIA; HUMAN; HYPERCALCEMIA; HYPERTENSION; INSULIN TREATMENT; KIDNEY FUNCTION; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PAKISTAN; PERIOPERATIVE PERIOD; PHEOCHROMOCYTOMA; PREOPERATIVE EVALUATION; REVIEW; TACHYCARDIA; UNITED STATES; X RAY; ADRENAL TUMOR; ADRENALECTOMY; BLOOD; METHODOLOGY; PATHOPHYSIOLOGY; PREOPERATIVE CARE; PROGNOSIS; SECRETION;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADRENERGIC ANTAGONISTS; ANESTHESIA; ANTIHYPERTENSIVE AGENTS; CATECHOLAMINES; HUMANS; HYPERTENSION; PHEOCHROMOCYTOMA; PREOPERATIVE CARE; PROGNOSIS;

EID: 34247897333     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Vuguin P, Perez N, Monsalve MM. Pheochromocytoma. Web article from eMedicine Specialties>Pediatrics>Oncology. Last updated: June 5, 2006. eMedicine from WebMD. www.emedicine.com/ped/topic1788.htm
2. Prys-Roberts C. Pheochromocytoma - recent progress in its management. Br J Anaesth 2000; 85:44-57.
3. Singh G, Kam P. An overview of anaesthetic issues in Pheochromocytoma. Ann Acad Med Singapore 1998; 27:843-8.
4. Kariya N, Nishi S, Hosono Y, Hamaoka N, Nishikawa K, Asada A. Cesarean section at 28 weeks' gestation with resection of pheochromocytoma: periopertive antihypertensive management. J Clin Anesth 2005; 17:296-9.
5. Kinney MA, Narr BJ, Warner MA. Perioperative Management of Pheochromocytoma. J Cardiothorasc Vasc Anesth 2002; 16:359-69.
6. Schif RL, Welsh GA. Perioperative evaluation and management of the patient with endocrine dysfunction. Med Clin N Am 2003; 87:175-92.
7. Greenspan FS, Forsham PH, eds: Pheochromocytoma. In: Basic and clinical endocrinology. 2nd ed. New York, NY: McGraw Hill 1986; pp. 336-44.
8. Catecholamines as Neurotransmitters/Hormones. © 1996-2004 University of Washington. http://courses.washington.edu/chat543/cvans/sfp/catechol.html
9. Bouloux PM. Multiple endocrine neoplasia. Surgery 1987; 1:1180-5.
10. Araki S, Kato M, Kase H, Okada K. Hyperdopaminemia may produce an increased outlet resistance of the prostatic urethra: a case report of malignant pheochromocytoma. J Urol 1995;153:1614-5 [Abstract].
11. Greene JP. New perspectives in pheochromocytoma. Urol Clin North Am 1989;16:487-503.
12. Manger WM, Gifford JW Jr. Phaeochromocytoma: a clinical overview. In: Swales JD ed. Textbook of Hypertension. Oxford: Blackwell Scientific 1994; pp. 941-58
13. Mihai R, Farndon JR Familial endocrine disease - genetics and early treatment. In: Farndon JR, ed. A companion to specialist surgical practice, Vol 5: Breast and Endocrine Surgery. London: W. B. Saunders 1997; pp. 113-42.
14. Tauzin-Fin P, Sesay M, Gosse P, Ballanger P. Effects of perioeprative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma. Br J Anaesth 2004; 92:512-7.
15. Chung PC, Ng YT, Hsieh JR, Yang MW, Li AH. Labetalol pretreatment reduces blood pressure instability during surgical resection of pheochromocytoma. J Formos Med Assoc 2006;105:189-93.
16. Fahmy N, Assad M, Bathijad P, Whittier FC. Postoperative acute pulmonary oedema: a rare presentation of pheochromocytoma. Clin Nephrol 1997; 48:122-4.
17. Hull CJ. Pheochromocytoma: diagnosis, preoperative preparation, and anaesthetic management. Br J Anaesth 1986; 58:1453-68.
18. Perel Y, Sclumberger M, Marguerite G, Alos N, Revillon y, Sommelet D, et al. Pheochromocytoma and paraganglionoma in children: a report of 24 cases of the French Society of Pediatric Oncology. Pediatr Hematol Oncol 1997; 14:413-22.
19. Jalil ND, Pattou PN, Combemale F, Chafuis Y, Henry JF, Peix JL, et al. Effectiveness and limits of preoperative imaging studies for localization of pheochromocytomas and paragangliomas: a review of 282 cases. Eur J Surg 1998; 164:23-8.
20. Serfas D, Shoback Dm, Lorell BH. Phaechromocytoma and hypertonic cardiomyopathy: apparent suppression of symptoms and noradrenaline secretion b calcium-chennel blockade. Lancet 1987;ii:711-3
21. Mardini MK. Echocardiographc findings in phaeochromocytoma. Chest 1981;3:394-6.
22. Emerson CE, Rainbird A. Use of a 'hospital-at-home' service for patient optimization before resection of pheochromocytoma. Br J Anaesth 2003;90:380-82.
23. Bravo EL. Pheochromocytoma. Curr Ther Endocrinol Metab 1997; 6:195-97.
24. Kinney MA, Warner ME, van Heerden JA, Horloiker TT, Young WF Jr, Maxrun PM, et al. Perianesthetic risks and outcomes of Pheochromocytoma and paraganglioma resection. Anesth Analg 2000; 91:1118-23.
25. Sloand EM, Thompson BT. Propranolol- induced pulmonary edema and shock in a patient with pheochromocytoma. Arch Intern Med 1984;144:173-4.
26. Shupak RC. Difficult anesthetic management during pheochromocytoma surgery. J Clin Anesth 1999;11:247-250.
27. Proye C, Thevenin D, Cecat P, Petillot P, Carnaille B, Verin P, et al. Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients. Surgery 1989; 106:1149-54.
28. Lee MK. Anaesthetic management for the removal of pheochromocytoma with neurolept anaesthesia using high dose fentanyl - a case report. Singapore Med J 1986; 27:158-62.
29. Bogdonof DI. Pheochromocytoma: specialist cases that all must be prepared to treat. J Cardiothorasc Vasc Anesth 2002; 16:267-9.
30. Desmonts JM, Marty J. Anaesthetic management of patients with pheochromocytoma. Br J Anaesth 1984; 56:781-9.
31. Dugas G, Fuller J, Singh S, Watson J. Pheochromocytoma and pregnancy: a case report and review of anesthetic management. Canadian Journal of Anesthesia 2004; 51:134-8.
32. Ueda N, Kitamura Y, Takaki O, Hayashi Y, Uihida O, Kuro M, et al. Anaesthetic management of pheochormocytoma associated with tricuspid atresia. Can J Anaesth 1991; 38:780-4.
33. Zakowski M, Kaufman B, Berguson P, et al: Esmolol use during resection of pheochromocytoma: Report of three cases. Anesthesiology 1989; 70:875-877.
34. James MFM. Use of magnesium sulphate in the anaesthetic management of phaechromocytoma: a review of 17 anaesthetics. Br J Anaesth 1989; 62:616-23.
35. Channa Ab, Mofti AB, Taylor GW, Mekki MO, Sheikh MH. Hypoglycaemic encephalopathy following surgery on phaeochromocytoma. Anaesthesia 1987; 42:1298-301.